Spontaneous chronic subdural hematoma (SDH) is a rare condition that could develop in association with hematologic disease. A 66-year-old male developed a chronic SDH as an initial manifestation of chronic myelomonocytic leukemia (CMML). He experienced recurrent chronic subdural hemorrhage and newly developed intracerebral hemorrhage. Considering the scheduled long-term chemotherapy, bilateral middle meningeal artery (MMA) embolization was performed to prevent recurrence of subdural hemorrhage. Although pancytopenia occurred during the 7 months' follow-up period, residual chronic subdural hemorrhage was absorbed without recurrence. To our best knowledge, this is the first report of CMML with spontaneous chronic SDH. MMA embolization is potentially a useful and safe treatment option in the challenging clinical situations with underlying pathologies.
INTRODUCTION
Chronic subdural hematoma (SDH) is commonly caused by trivial trauma followed by tearing of the cortical bridge veins or fragile vessels in the neomembrane, and repeated microhemorrhage.
12)
Spontaneous chronic SDH is a very rare condition which can be developed in association with rupture of a cortical vessel, tumor, metastasis, or blood dyscrasias. 14) 20) We report a 66-year-old man who developed spontaneous chronic SDH that presented as the initial manifestation of chronic myelomonocytic leukemia (CMML). In addition, we reviewed the literature on chronic SDH associated with leukemic neoplasm and middle meningeal artery (MMA) embolization to prevent recurrence of chronic SDH in high-risk patients.
CASE REPORT

Admission for chronic subdural hemorrhage
A 66-year-old right-handed male with a past medical history of hypertension and diabetes mellitus was admitted to our hospital for nausea, vomiting, and orbital pain for one day prior. He was on amolodipine and linagliptin. On the day of admission, the patient nificant mass effect (Fig. 1A) . The patient was admitted to the neurosurgery department and underwent burr-hole drainage. Postoperative CT scan revealed decreased amount of SDH, and the symptoms of the patient were disappeared (Fig. 1B) . hemorrhage in left insular-temporal lobe subcortical white matter with surrounding edema. Also, scanty amount of SDH was noted in both fronto-temporo-parietal lobes (Fig. 2) . The signal intensity of left-sided hematoma was consistent with early late acute stage, and that of right-sided hematoma was consistent with subacute stage.
Detection of chronic myelomonocytic leukemia
Middle meningeal artery (MMA) embolization
Due to expected long-term chemotherapy and possibility of repeated intracranial hemorrhage, further management was required. For prevention of recurrent SDH, bilateral MMA embolization was conducted under local anesthesia (Fig. 3) . (Table 1) .
Brain CT performed 5 months later revealed complete resolution of subdural hemorrhage (Fig. 4) . Organization. 25) It has an inherent risk for transformation to acute myeloid leukemia. The annual incidence of CMML is estimated at 4 per 100,000.
DISCUSSION
19)26)
The median age at diagnosis of disease ranges from 71 to 74 years, with a male predominance (1.5-3:1).
2)22)
Chemotherapy such as etoposide, cytarabine, all-trans retinoic acid, topotecan, 9-nitro-campothecin (topoisomerase inhibitor), and lonafarnib (farnesyltransferase inhibitor) has been the mainstay of treatment for chronic myeloid leukemia (CML) since the 1990s. 5)7) However, the outcome has been disappointing due to the low response rates and high rates of toxicities. The overall response rates of these hypomethylating agents are estimated at 30-40%, with complete remission rates of 15%.
2)3)
This case is the second case report of non-traumatic SDH associated with CMML, to our best knowledge.
In 1912, Ichimura et al. In these situations, repeated burr-hole surgery or removal of the outer membrane with craniotomy has risks of bleeding or infection.
11)15)
Since first introduced in 2000 for patient with liver cirrhosis, transarterial MMA embolization has emerged as the treatment option for frequently recurring chronic SDH. 13) 23) The therapeutic rationale follows from pathologic identification. Tanaka et al. 24) identified that arteries originating from branches of the MMA that entered the outer membrane through histological study of dura mater and outer membrane.
MMA contributes to the development of chronic SDH, by providing feeding vessels to the outer membrane that is connected with the dura matter. Angiographic 
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